Optimal cut-off points for waist circumference in the definition of metabolic syndrome in Chile.
Central obesity
Metabolic syndrome
Waist circumference
Journal
Public health nutrition
ISSN: 1475-2727
Titre abrégé: Public Health Nutr
Pays: England
ID NLM: 9808463
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
4
7
2020
medline:
12
8
2021
entrez:
4
7
2020
Statut:
ppublish
Résumé
To identify sex-specific cut-off points for waist circumference (WC) in the definition of metabolic syndrome (MetS) for the Chilean adult population. MetS was defined as the presence of at least two out of four of the following criteria: TAG ≥1·7 mmol/l; HDL-cholesterol: <1·3 mmol/l in women and <1·0 mmol/l in men; systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg; and fasting glucose ≥ 5·6 mmol/l or current treatment for diabetes. The receiver operating characteristics curve and the AUC were computed to derive the specificity and sensitivity using bootstrapping (10 000 iterations restricted to have at least between 40 and 60 % of the original population). The optimal cut-off point for the Chilean population was computed by sex. A representative sample of the Chilean population aged ≥15 years. 8182 participants (60 % women) from the three available Chilean National Health Surveys conducted in 2003, 2009-2010 and 2016-2017. WC had a good predictive ability for MetS (AUC for men 0·74 (95 % CI 0·72, 0·76); AUC for women 0·71 (95 % CI 0·68, 0·73)). The optimal cut-off points for WC, in the definition of MetS, were 92·3 cm (95 % CI 90·5, 94·4) and 87·6 cm (95 % CI 85·8, 92·1) for men and women, respectively. The mentioned cut-off points should be used for WC in the definition of MetS in Chile. As a result, the current recommendation (WHO/International Diabetes Federation) for WC, in the identification of MetS, is not supported by these findings in a representative sample of the Chilean adult population.
Identifiants
pubmed: 32618236
pii: S1368980020001469
doi: 10.1017/S1368980020001469
pmc: PMC10200507
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2898-2903Commentaires et corrections
Type : CommentIn
Références
Diabet Med. 2012 Nov;29(11):1395-8
pubmed: 22443340
PLoS One. 2018 Mar 26;13(3):e0194644
pubmed: 29579094
Lancet. 2005 Sep 24-30;366(9491):1059-62
pubmed: 16182882
PLoS Med. 2015 Jul 28;12(7):e1001859
pubmed: 26218734
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Diabetol Metab Syndr. 2018 Jun 15;10:49
pubmed: 29946366
Dis Model Mech. 2009 May-Jun;2(5-6):231-7
pubmed: 19407331
J Assoc Physicians India. 2009 Feb;57:163-70
pubmed: 19582986
Diabet Med. 1998 Jul;15(7):539-53
pubmed: 9686693
Obesity (Silver Spring). 2010 Sep;18(9):1821-6
pubmed: 20075855
Diabetes. 1988 Dec;37(12):1595-607
pubmed: 3056758
J Law Med Ethics. 2010 Fall;38(3):490-507
pubmed: 20880237
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
BMC Med. 2011 May 05;9:48
pubmed: 21542944
Circulation. 2002 Dec 17;106(25):3143-421
pubmed: 12485966
Salud Publica Mex. 2014 Apr;56(2):146-53
pubmed: 25014421
Can Fam Physician. 2012 Apr;58(4):389-93, e196-201
pubmed: 22611605
Diabetes Care. 1998 Nov;21(11):1828-35
pubmed: 9802729
Diabetes Res Clin Pract. 2011 Aug;93(2):243-247
pubmed: 21632141